GT BiopharmaGTBP 
$2.256.64%24h
6.64%24h
Global rank21614
Market cap$93.19M
Change 7d1.81%
YTD Performance-71.37%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of GT Biopharma (GTBP)
As of November 2024, GT Biopharma has a market cap of $93.19M. This makes GT Biopharma the world's 21614th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of GT Biopharma from 2018 to 2024
-
Value:-
Market cap history of GT Biopharma from 2018 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $165.68M | -47.71% |
| 2023 | $316.86M | -71.22% |
| 2022 | $1.10B | -70.95% |
| 2021 | $3.79B | -57.69% |
| 2020 | $8.96B | 423.46% |
| 2019 | $1.71B | -87.54% |
| 2018 | $13.73B | - |
GTBP Market Cap Today is $93.19M 6.64% - 19 Nov 2024
View largest stocks by market cap 
